Biohaven Ltd. (BHVN) Form 8-K — Aug 7, 2026
Biohaven Ltd. announced in an 8-K that its Board of Directors appointed John Yetimoglu as a director effective August 6, 2026, per an appointment made on August 3, 2026. Yetimoglu will serve in the director class whose term expires at the company's 2027 Annual Meeting of Shareholders and has joined the Board's Nominating and Governance Committee. The filing states there are no arrangements behind his selection and no reportable related-party transactions.
Key figures
- Effective date
- 2026-08-06
- Director class term
- expires at the 2027 Annual Meeting of Shareholders
- Option grant value usd
- 713875
- Option vesting schedule
- 25% on grant and 25% on each of the following three anniversaries of grant
- Annual director retainer usd
- 57000
Price after filing
1 day: 0.0%7 days: -0.1%30 days: +7.0%
Close on the filing date to close N calendar days later (from $14.66). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.